Wuhan, China
Pfizer is planning to establish a research and development center in Wuhan, China. Supporting early clinical development of drugs, the R&D facility will foster collaboration with local universities and research institutes to create innovative biopharmaceutical projects. Housing 200 employees, the facility will be located at Biolake, also known as the Wuhan National Bioindustry Base.
